Skip To Main Content
Shruti Chaturvedi on Muck Rack

Shruti Chaturvedi

  • Founder, India Action Project
Ahmedabad, Genoa, India
As seen in: Wiley, Wiley Online Library, Hindustan Times, MDPI, ANI, HCP Live, Texas Medical Center, LatestLY, Justdial, Asian News International and
moved to threads @ shrutichaturvedii

Get in touch with Shruti

Contact Shruti, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Exploratory research in immune TTP and other ultra-rare diseases—Balancing statistical idealism with pragmatic discovery

|
By Shruti Chaturvedi, Mitani AA, Griggs RC
| Wiley Online Library Verified
No abstract is available for this article. DATA AVAILABILITY STATEMENT Data sharing not applicable to this article as no datasets were generated or analysed during the current study. REFERENCES 1, , , , , , et al. Risk factors for silent cerebral infarction in immune-mediated thrombotic thrombocytopenic survivors. Br J Haematol. 2026; 208(2): 654–660. https://doi.org/10.1111/bjh.70256 2, , , , , , et al.
Open in Who Shared Issue with article?

University of Southampton expands to India with new campus in 2025: British Council director highlights UK's commitment for Indian students Original

|
By Shruti Chaturvedi
| ANI Verified
New Delhi [India], January 31 (ANI): The first UK campus in India will open its doors as the University of Southampton begins operations in Gurugram in August 2025, said Alison Barrett MBE, Country Director India, British Council highlighting the UK's commitment to welcoming Indian students, with over 173,000 currently studying in the UK.
Open in Who Shared View Duplicates (63) Issue with article?

"Cardiovascular Disease and Stroke in Immune TTP-Challenges and Opportu" by Senthil Sukumar, Marshall A Mazepa et al.

|
By Senthil Sukumar, Marshall A. Mazepa, Shruti Chaturvedi
| Texas Medical Center
Keywords TTP, TMA, cardiovascular disease, stroke Abstract Advances in the management of immune thrombotic thrombocytopenic purpura (iTTP) have dramatically improved outcomes of acute TTP episodes, and TTP is now treated as a chronic, relapsing disorder.
Open in Who Shared Issue with article?
See all 20 licensed articles (22 Total)